The human microbiome represents the collection of trillions of microbes that live in an intimate association with the human body and impact important body functions.
Microbiome science is giving rise to an unprecedented opportunity for the development of new microbial strategies for the management of harmful conditions in humans. Intervention on the microbiome, like the recent successful fecal microbiota transplants for recurrent Clostridium difficile infection, has boosted the interest in exploring, understanding and developing new probiotic and live bio-therapeutic microorganisms from the microbiome.
Some of the most promising types of bacteria are anaerobic bacteria. These microbes are typically very sensitive to oxygen, which poses new challenges to the industry in terms of screening and selection as well as production and formulation.
What do we want to achieve?
As a global leader in the production of probiotic bacteria, we use the strongest technology platforms in the industry. In order to help fulfill the promise of this breakthrough microbiome science area, we are investing heavily in ways to tailor and expand our discovery and production platforms, to allow us to accelerate innovation and product development.
Want to learn more?
Please contact us for more information on the microbiome and what we can offer.